Actuate Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Actuate Therapeutics, Inc. has scheduled its 2026 Annual Meeting of Stockholders for May 21, 2026, to vote on director elections and auditor ratification.
NASDAQ
Actuate Therapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Actuate Therapeutics announces its 2025 annual meeting of stockholders to be held virtually on May 22, 2025, to vote on director elections and the ratification of the independent accounting firm.